This section includes information and resources about Hypertension for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
FDA approves Twynsta® (telmisartan plus amlodipine) a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours
Expedition to Mount Everest offers new insights into chronic disease
New investigational combination telmisartan and amlodipine shows effective and well-tolerated 24-hour blood pressure control in hypertensive patients at risk of cardiovascular events
Professor Albertino Damasceno is announced as winner of the ISH Boehringer Ingelheim Developing World Award during the 2008 International Society of Hypertension (ISH) Biennial Scientific Meeting
Micardis®-based regimens help more patients achieve their blood pressure goals